{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:01:14Z","timestamp":1760061674735,"version":"3.37.3"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypertension and chronic kidney disease (CKD) are closely linked pathological processes. Combating high blood pressure (BP) is an essential part of preventing CKD progression and reducing cardiovascular (CV) risk. Data from recent randomized controlled trials on patients at high CV risk showed the beneficial effects of intensive action to meet BP targets on mortality related to CV disease. The impact of meeting such targets on renal function is still unclear, however, particularly for patients with CKD. This issue has been the object of several post hoc analyses because lowering BP definitely has a nephroprotective role, but the early decline in glomerular filtration rate (GFR) associated with antihypertensive therapies and strict BP targets is still a concern in nephrology clinical practice. The present review discusses the results of studies on this topic, focusing specifically on the clinical significance of early GFR decline in response to treatment with angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker, or to different BP targets, in terms of renal and CV outcomes, and how this tips the balance towards continuing or discontinuing antihypertensive therapy.<\/jats:p>","DOI":"10.1093\/ndt\/gfaa171","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T20:07:53Z","timestamp":1604261273000},"page":"222-229","source":"Crossref","is-referenced-by-count":2,"title":["The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomes"],"prefix":"10.1093","volume":"37","author":[{"given":"Lorenzo","family":"Signorini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-6196","authenticated-orcid":false,"given":"Gianluigi","family":"Zaza","sequence":"additional","affiliation":[{"name":"Renal Unit, Department of Medicine, University Hospital of Verona, Verona, Italia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-2370","authenticated-orcid":false,"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[{"name":"Renal Unit, Department of Medicine, University Hospital of Verona, Verona, Italia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"2022030904263110200_gfaa171-B1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"2022030904263110200_gfaa171-B2","first-page":"683","article-title":"The role of blood pressure as a risk factor for renal disease","volume":"10","author":"Whelton","year":"1996","journal-title":"J Hum Hypertens"},{"key":"2022030904263110200_gfaa171-B3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00042.2012","article-title":"Renal autoregulation in health and disease","volume":"95","author":"Carlstr\u00f6m","year":"2015","journal-title":"Physiol Rev"},{"key":"2022030904263110200_gfaa171-B4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"2022030904263110200_gfaa171-B5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40620-018-0526-y","article-title":"The 2018 ESC\/ESH hypertension guidelines: should nephrologists always stop at the lower boundary?","volume":"31","author":"Reboldi","year":"2018","journal-title":"J Nephrol"},{"key":"2022030904263110200_gfaa171-B6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2022030904263110200_gfaa171-B7","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2022030904263110200_gfaa171-B8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2022030904263110200_gfaa171-B9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/jamainternmed.2017.0197","article-title":"Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis","volume":"177","author":"Tsai","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2022030904263110200_gfaa171-B10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1681\/ASN.2016030326","article-title":"BP control and long-term risk of ESRD and mortality","volume":"28","author":"Ku","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263110200_gfaa171-B11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.kint.2018.12.025","article-title":"Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Cheung","year":"2019","journal-title":"Kidney Int"},{"key":"2022030904263110200_gfaa171-B12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","article-title":"GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials","volume":"64","author":"Lambers Heerspink","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2022030904263110200_gfaa171-B13","doi-asserted-by":"crossref","first-page":"e012749","DOI":"10.1161\/JAHA.119.012749","article-title":"Effect of blood pressure control on long-term risk of end-stage renal disease and death among subgroups of patients with chronic kidney disease","volume":"8","author":"Ku","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2022030904263110200_gfaa171-B14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000186033","article-title":"Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study","volume":"55","author":"Mann","year":"1990","journal-title":"Nephron"},{"key":"2022030904263110200_gfaa171-B15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ki.1997.111","article-title":"A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function","volume":"51","author":"Apperloo","year":"1997","journal-title":"Kidney Int"},{"key":"2022030904263110200_gfaa171-B16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"2022030904263110200_gfaa171-B17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"key":"2022030904263110200_gfaa171-B18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1681\/ASN.2018121261","article-title":"Implications of early decline in eGFR due to intensive BP control for cardiovascular outcomes in SPRINT","volume":"30","author":"Beddhu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263110200_gfaa171-B19","doi-asserted-by":"crossref","first-page":"e013145","DOI":"10.1161\/JAHA.119.013145","article-title":"Early rapid decline in kidney function as a beneficial sign after starting antihypertensive medication","volume":"8","author":"Beige","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2022030904263110200_gfaa171-B20","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"2022030904263110200_gfaa171-B21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","volume":"6","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022030904263110200_gfaa171-B22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.115.019657","article-title":"Effect of intensive versus usual blood pressure control on kidney function among individuals with prior lacunar stroke: a post hoc analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) randomized trial","volume":"134","author":"Peralta","year":"2016","journal-title":"Circulation"},{"key":"2022030904263110200_gfaa171-B23","doi-asserted-by":"crossref","first-page":"e012366","DOI":"10.1161\/JAHA.119.012366","article-title":"Early rapid decline in kidney function in medically managed patients with atherosclerotic renal artery stenosis","volume":"8","author":"Cooper","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2022030904263110200_gfaa171-B24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.kint.2016.09.038","article-title":"Acute change in glomerular filtration rate with inhibition of the renin-angiotensinsystem does not predict subsequent renal and cardiovascular outcomes","volume":"91","author":"Clase","year":"2017","journal-title":"Kidney Int"},{"key":"2022030904263110200_gfaa171-B25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.118.12060","article-title":"Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus","volume":"73","author":"Ohkuma","year":"2019","journal-title":"Hypertension"},{"key":"2022030904263110200_gfaa171-B26","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1681\/ASN.2017010040","article-title":"Acute declines in renal function during intensive BP lowering: implications for future ESRD risk","volume":"28","author":"Ku","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022030904263110200_gfaa171-B27","doi-asserted-by":"crossref","first-page":"j791","DOI":"10.1136\/bmj.j791","article-title":"Serum creatinine elevation after renin-angiotensin system blockade and long-term cardiorenal risks: cohort study","volume":"356","author":"Schmidt","year":"2017","journal-title":"BMJ"},{"key":"2022030904263110200_gfaa171-B28","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2215\/CJN.03060319","article-title":"Association of acute increases in plasma creatinine after renin-angiotensin blockade with subsequent outcomes","volume":"14","author":"Fu","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022030904263110200_gfaa171-B29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M18-1037","article-title":"Kidney damage biomarkers andincident chronic kidney disease during blood pressure reduction: a case-control study","volume":"169","author":"Zhang","year":"2018","journal-title":"Ann Intern Med"},{"key":"2022030904263110200_gfaa171-B30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2018.07.015","article-title":"Effects of intensive blood pressure lowering on kidney tubule injuryin CKD: a longitudinal subgroup analysis in SPRINT","volume":"73","author":"Malhotra","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2022030904263110200_gfaa171-B31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.kint.2016.11.019","article-title":"Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition: clinicalimplications","volume":"91","author":"Weir","year":"2017","journal-title":"Kidney Int"},{"key":"2022030904263110200_gfaa171-B32","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N Engl J Med"},{"key":"2022030904263110200_gfaa171-B33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/M16-2966","article-title":"A secondary analysis of a randomizedtrial","volume":"167","author":"Beddhu","year":"2017","journal-title":"Ann Intern Med"},{"key":"2022030904263110200_gfaa171-B34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra020676","article-title":"Renal dysfunction complicating the treatment of hypertension","volume":"347","author":"Palmer","year":"2002","journal-title":"N Engl J Med"},{"key":"2022030904263110200_gfaa171-B35","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1152\/ajpregu.90677.2008","article-title":"Regional decreases in renal oxygenation during graded acute renal arterial stenosis: a case for renal ischemia","volume":"296","author":"Warner","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022030904263110200_gfaa171-B36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.118.11082","article-title":"Emerging paradigms in chronic kidney ischemia","volume":"72","author":"Eirin","year":"2018","journal-title":"Hypertension"},{"key":"2022030904263110200_gfaa171-B37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40620-018-0535-x","article-title":"J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?","volume":"32","author":"Robles","year":"2019","journal-title":"J Nephrol"},{"key":"2022030904263110200_gfaa171-B38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/15701611113116660149","article-title":"Molecular mechanisms of renal blood flow autoregulation","volume":"12","author":"Burke","year":"2014","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/2\/222\/42771821\/gfaa171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/2\/222\/42771821\/gfaa171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T04:32:10Z","timestamp":1646800330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/2\/222\/5957494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,6]]},"published-print":{"date-parts":[[2022,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaa171","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"type":"print","value":"0931-0509"},{"type":"electronic","value":"1460-2385"}],"subject":[],"published-other":{"date-parts":[[2022,2]]},"published":{"date-parts":[[2020,11,6]]}}}